New product: Alymsys (bevacizumab) 25mg/ml concentrate for solution for infusion
Alymsys is a biosimilar medicinal product licensed for treatment of carcinoma of colon or rectum, breast, non-small cell lung, renal cell, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of cervix. Trials found it highly similar to Avastin.
Source:
electronic Medicines compendium